595 related articles for article (PubMed ID: 31266025)
1. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
Zhang Q; Conley SM; Li G; Yuan X; Li PL
Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
[TBL] [Abstract][Full Text] [Related]
3. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
[TBL] [Abstract][Full Text] [Related]
5. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
[TBL] [Abstract][Full Text] [Related]
6. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
Abais JM; Xia M; Li G; Gehr TW; Boini KM; Li PL
Free Radic Biol Med; 2014 Feb; 67():211-20. PubMed ID: 24140862
[TBL] [Abstract][Full Text] [Related]
7. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.
Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL
Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887
[TBL] [Abstract][Full Text] [Related]
8. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
[TBL] [Abstract][Full Text] [Related]
9. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
[TBL] [Abstract][Full Text] [Related]
10. Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia.
Huang D; Li G; Bhat OM; Zou Y; Li N; Ritter JK; Li PL
Am J Pathol; 2022 Jan; 192(1):43-55. PubMed ID: 34717894
[TBL] [Abstract][Full Text] [Related]
11. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
[TBL] [Abstract][Full Text] [Related]
13. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
[TBL] [Abstract][Full Text] [Related]
15. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.
Xia M; Conley SM; Li G; Li PL; Boini KM
Cell Physiol Biochem; 2014; 34(3):829-41. PubMed ID: 25171193
[TBL] [Abstract][Full Text] [Related]
18. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
[TBL] [Abstract][Full Text] [Related]
19. Regulation of TRPML1 channel activity and inflammatory exosome release by endogenously produced reactive oxygen species in mouse podocytes.
Li G; Huang D; Li N; Ritter JK; Li PL
Redox Biol; 2021 Jul; 43():102013. PubMed ID: 34030116
[TBL] [Abstract][Full Text] [Related]
20. Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury.
Koka S; Surineni S; Singh GB; Boini KM
Aging (Albany NY); 2023 Nov; 15(22):12738-12748. PubMed ID: 38032896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
